Back to Crohns Disease And Colitis
NCT06069167
NCT06069167
Who may be able to join
Who might be able to join this trial:
- You are at least 18 years old (male or female)
- You have been diagnosed with inflammatory bowel disease (such as Crohn's disease or ulcerative colitis) for at least 3 months, based on recognised European guidelines
- You have been fully informed about how the study works and you do not object to taking part or to your data being used
- You are covered by or entitled to social security (health insurance or a similar scheme)
Who may not be able to join:
- You are not able to follow or complete the study procedures for any reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
Paris IBD Center
Registry
clinicaltrials_gov
Start date
12 October 2023
Est. completion
22 March 2024
Where this trial is recruiting
🇫🇷 France
Primary endpoints
Prevalence of bowel urgency in a cohort of patients with inflammatory bowel disease
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.